Published on: 2026-03-31
As of March 31, 2026, the HMH IPO has been launched but not officially priced yet. The filed offer is for 10.52 million shares at an expected price range of $19 to $22 per share, with the stock set to trade under HMH once the registration becomes effective.
Market calendars typically indicate March 31 for pricing and April 1 for trading; however, these dates should be considered as expected rather than final, as the exchange itself states that published IPO dates are estimates based on filings.
The key question for investors is not if the deal is live, but whether the valuation is reasonable.
| Item | Latest available detail |
|---|---|
| IPO status | Launched, not yet finally priced |
| Shares offered | 10.52 million |
| Price range | $19 to $22 |
| Extra allotment option | 1.578 million shares |
| Expected pricing | March 31, 2026 |
| Expected trading debut | April 1, 2026 |
| Ticker | HMH |
| Post-IPO share count | 44 million |
The best way to evaluate this deal is by comparing the valuation range to HMH's most recent operating numbers.
| Scenario | Share Price | Implied Market Cap | Enterprise Value* | EV / Revenue** | EV / EBITDA |
|---|---|---|---|---|---|
| Low end | $19.00 | $818.8M | $922.8M | about 1.12x | about 5.46x |
| Midpoint | $20.50 | $883.5M | $987.5M | about 1.20x | about 5.84x |
| High end | $22.00 | $948.1M | $1,052.1M | about 1.27x | about 6.23x |
* Enterprise value here uses implied equity value plus year-end 2025 net debt of $104 million.
** The revenue base is based on FY2025 revenue, rounded to $826 million as stated in the company's latest earnings release.
According to Reuters, the company was targeting a valuation of up to $948 million at the top of the range.
Approximately 43.1 million shares will be outstanding after the IPO based on a basic market capitalization perspective. Using that share count, the implied equity valuation comes out near $818.8 million at $19, $883.5 million at the $20.50 midpoint, and $948.1 million at $22.
At $19, the answer looks fairly positive. At $20.50, it still appears reasonable if investors believe that cash flow and service-heavy revenue can remain stable. At $22, the deal still does not look wildly expensive on sales or earnings, but the margin for error becomes thinner because 2025 growth was not especially strong.
Therefore, the HMH IPO seems reasonably priced. The price range does not look stretched, the business is profitable, and the revenue mix has a steadier feel than many cyclical industrial names.
At the same time, this is not a fast-growth listing. It is a cash-generating industrial IPO that likely needs disciplined expectations more than excitement.
The first thing to watch is the final IPO price, because this deal leaves little room for a sloppy entry.
A higher-than-expected pricing could limit upside and make the stock more vulnerable if sentiment softens after listing.
The second thing to watch is the final share count and dilution math in the priced prospectus, since that will confirm the exact market capitalization.
Small changes in share count can significantly impact a company's perceived value on listing day.
The third thing to watch is whether the company can keep its EBITDA margin and cash flow steady if revenue remains mixed. That will help determine whether the business model is truly resilient or simply benefiting from favorable trailing conditions.
The fourth thing to watch is the order trend, because a company can appear healthy on trailing numbers while future demand is quietly weakening.
If orders begin to decline, it may signal potential revenue pressures in the future.
As of March 31, the offer has been launched but not finalized in price. Market calendars suggest that pricing is anticipated on March 31 and trading will begin on April 1; however, these dates remain estimates until the final prospectus becomes effective.
The filed HMH IPO price range is $19 to $22 per share for 10.52 million shares, with an additional 1.578 million share option for underwriters.
Yes. HMH reported $46.1 million in net income for 2025, along with $169 million of adjusted EBITDA and $106 million of free cash flow.
Disclaimer: This material is for general information purposes only and is not intended as (and should not be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by EBC or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.
